This stock is crafting a cure for Huntington's – and it's making progress
Neurizon Therapeutics (ASX:NUZ) has declared that its in-house product NUZ-001 Sulfone granted neuroprotective effects...
Currently unlisted.
Proposed listing date: 24 JUNE 2025 1:00 PM AEST ##
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.